干细胞治疗肝硬化的研究进展  

Research progress of stem cell therapy for liver cirrhosis

作　　者：郭春柳 黄晓曦[1] GUO Chun-liu;HUANG Xiao-xi(Department of Gastroenterology,Affliated Haikou Hospital of Xiangya Medical College of Central South University,Haikou 570208,China)

机构地区：[1]中南大学湘雅医学院附属海口医院消化内科,海南海口570208

出　　处：《海南医学院学报》2022年第2期152-156,共5页Journal of Hainan Medical University

基　　金：海南省科技厅国际合作项目(KJHZ2015-19)。

摘　　要：肝硬化是由各种慢性肝损伤导致的终末阶段,晚期患者常出现多种并发症而死亡,目前尚缺乏有效的治疗方法。近年来,基于干细胞移植技术治疗肝硬化成为新的研究热点,国内外学者对此开展了一系列基础及临床研究,并取得了一定成果,为肝硬化的治疗提供了新的选择。本文就各种类型的干细胞在肝硬化治疗中的研究进展作一综述。Liver cirrhosis is the terminal stage caused by various chronic liver injuries.There are many complications and death in the late stage.There is no effective treatment method at present.In recent years,with the rapid development of regenera-tive medicine,the treatment of liver cirrhosis based on stem cell transplantation technology has become a new research hotspot.Scholars at home and abroad have carried out a series of basic and clinical researches,and achieved certain results,which brings new hope for the majority of patients with liver cirrhosis.This article reviews the research progress of various types of stem cells in the treatment of liver cirrhosis.

关 键 词：干细胞 肝硬化 治疗 

分 类 号：R575.2[医药卫生—消化系统]